- ECHA
- Consultations
- Consultation sur les dérogations aux critères d’exclusion
- Consultations antérieures sur les dérogations aux critères d’exclusion
Consultations antérieures sur les dérogations aux critères d’exclusion
Consultations antérieures sur les dérogations aux critères d’exclusion
The closed consultations on the derogations to the exclusion criteria as laid down in Article 5(2) of the BPR are listed in the table below.
There are currently no ongoing consultations.
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) | 8 | 262-104-4 | 60207-90-1 | 17/06/2022 | 15/08/2022 | Details |
2,2-dibromo-2-cyanoacetamide (DBNPA) | PT 6 | 233-539-7 | 10222-01-2 | 03/11/2023 | 04/01/2024 | Details |
2,2-dibromo-2-cyanoacetamide; [DBNPA] | 4 | 233-539-7 | 10222-01-2 | 11/10/2019 | 10/12/2019 | Details |
Cholecalciferol | 14 | 200-673-2 | 67-97-0 | 01/02/2024 | 25/04/2024 | Details |
Cholecalciferol | 14 | 200-673-2 | 67-97-0 | 01/02/2018 | 01/04/2018 | Details |
Creosote | PT08 | 232-287-5 | 8001-58-9 | 29/01/2021 | 30/03/2021 | Details |
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 1:1) (originally notified as HPT) | 2, 6, 11, 13 | - | - | 04/09/2017 | 04/11/2017 | Details |
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 3:2) (originally notified as MBO) | 2, 6, 11, 12, 13 | - | - | 04/09/2017 | 04/11/2017 | Details |